The vitamin-E analog trolox and the NMDA antagonist MK-801 protect pyramidal neurons in hippocampal slice cultures from IL-1β-induced neurodegeneration
- 103 Downloads
The neurotoxic effect of the pro-inflammatory cytokine interleukin (IL)-1β was studied in monolayer cultures, obtained using roller-drum incubation of hippocampal slices from neonatal Sprague Dawley rats. Following exposure to recombinant rat IL-1β for four days, a concentration dependent loss was observed in the number of NMDAR1 receptor subunit immunoreactive pyramidal neurons in the cultures, reaching significance at 10 ng/ml rIL-1β. Also incubation with recombinant mouse IL-1β caused a loss of pyramidal neurons, with a significant effect at a concentration of 30 pg/ml. The vitamin E analog trolox (30 μM) was found to exert a protective effect against the rIL-1β-induced neuronal degeneration. A neuroprotective action against rIL-1β was also found after co-incubation with the NMDA antagonist dizocilpine (MK-801; 30 μM), while no protection was found with the GABAA mimetic clomethiazole. Hence, the proinflammatory cytokine IL-1β is neurotoxic to hippocampal pyramidal neurons when studied in anin vitro system with advanced phenotypic characteristics. The neuroprotective effects exerted by trolox and MK-801 suggest that free radicals and NMDA receptor-mediated processes are involved in IL-1β-induced neurodegeneration.
KeywordsNeuroinflammation Cytokines Interleukin-1β Hippocampus Neurodegeneration Organotypic cultures
Unable to display preview. Download preview PDF.
- Heyes MP, K Saito, J Crowley, LE Davies, MA Demitrak, M Der, L Dilling, MPJ Kruesi, A Lackner, SA Larsen, K Lee, H Leonard, SP Markey, A Martin, S Milstein, MM Mouradian, MR Pranzatelli, BJ Querry, A Salazar, M Smith, SE Straus, T Sutherland, S Swedo and WW Tourtellotte (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.Brain 115, 1249–1273.PubMedCrossRefGoogle Scholar
- Kogure KJ, J Tanaka and T Araki (1998) The mechanism of ischemia-induced cell injury. The membrane theory.Neurochem. Pathol. 9, 145–170.Google Scholar
- Köhler C, LG Eriksson, E Okuno and RC Schwarcz (1988) Localization of quinolinic acid metabolizing enzymes in the rat brain. Immunohistological studies using antibodies to 3-hydroxyanthranilic acid oxygenase and quinolinic acid phosphoribosyl-transferase.Neuroscience 27, 49–76.PubMedCrossRefGoogle Scholar
- Pringle AK, N Niyadurupola, P Johns, DC Anthony and F Iannotti (2001) Interleukin-1β exacerbates hypoxia-induced neuronal damage, but attenuates toxicity produced by simulated ischaemia and excitotoxicity in rat organotypic hippocampal slice cultures.Neurosci. Lett. 305, 29–32.PubMedCrossRefGoogle Scholar
- Rothwell NJ (1991) Functions and mechanisms of interleukin-1 in brain.TINS 12, 430–435.Google Scholar
- Vezzani A, M Conti, A De Luigi, T Ravizza, D Moneta, F Marchesi and MG De Simoni (1999) Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures.J. Neurosci. 19, 5054–5065.PubMedGoogle Scholar
- von Coelln R, K Unsicker and K Krieglstein (1995) Screening of interleukins for survival-promoting effects on cultured mesencephalic dopaminergic neurons from embryonic rat brain.Brain Res. Dev. Brain Res. 89, 150–151.Google Scholar